Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients

Skeletal muscle depletion is common in patients with advanced cancer and may be associated with a poor outcome. To investigate whether the changes in skeletal muscle in metastatic renal cell carcinoma (mRCC) patients receiving targeted therapy are associated with clinical outcome, we undertook an ob...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Sci Rep
Main Authors: Gu, Weijie, Wu, Junlong, Liu, Xiaohang, Zhang, Hailiang, Shi, Guohai, Zhu, Yao, Ye, Dingwei
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group UK 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5548774/
https://ncbi.nlm.nih.gov/pubmed/28790354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-07955-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker